These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 21586182)

  • 1. [Amyloid-plaque imaging of the brain using PET].
    Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
    Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
    Leinonen V; Alafuzoff I; Aalto S; Suotunen T; Savolainen S; Någren K; Tapiola T; Pirttilä T; Rinne J; Jääskeläinen JE; Soininen H; Rinne JO
    Arch Neurol; 2008 Oct; 65(10):1304-9. PubMed ID: 18695050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
    Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
    J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.
    Wiley CA; Lopresti BJ; Venneti S; Price J; Klunk WE; DeKosky ST; Mathis CA
    Arch Neurol; 2009 Jan; 66(1):60-7. PubMed ID: 19139300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
    Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.
    Technol Eval Cent Assess Program Exec Summ; 2013 Feb; 27(5):1-4. PubMed ID: 23589929
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.
    Verhoeff NP; Wilson AA; Takeshita S; Trop L; Hussey D; Singh K; Kung HF; Kung MP; Houle S
    Am J Geriatr Psychiatry; 2004; 12(6):584-95. PubMed ID: 15545326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
    Huddleston DE; Small SA
    Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy support for the validity of Pittsburgh compound B positron emission tomography with a twist.
    Klunk WE
    Arch Neurol; 2008 Oct; 65(10):1281-3. PubMed ID: 18852340
    [No Abstract]   [Full Text] [Related]  

  • 12. Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.
    Villemagne VL; Rowe CC
    J Alzheimers Dis; 2013; 33 Suppl 1():S349-59. PubMed ID: 22710919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand.
    Juréus A; Swahn BM; Sandell J; Jeppsson F; Johnson AE; Johnström P; Neelissen JA; Sunnemark D; Farde L; Svensson SP
    J Neurochem; 2010 Aug; 114(3):784-94. PubMed ID: 20477945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
    Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
    Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
    Kudo Y
    Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounds for imaging amyloid-β deposits in an Alzheimer's brain: a patent review.
    Tu P; Fu H; Cui M
    Expert Opin Ther Pat; 2015 Apr; 25(4):413-23. PubMed ID: 25746836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of PET-imaging probes of β-amyloid plaques.
    Koo J; Byun Y
    Arch Pharm Res; 2013 Oct; 36(10):1178-84. PubMed ID: 23812777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Nguyen GAH; Liang C; Mukherjee J
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.